Stock screener

AXSM

Conviction 31HealthcareScan · Thu, Sep 24, 2026

Axsome Therapeutics, Inc. (AXSM) closed at $196.14 (+1.39%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 39, RS Rating 86, -23.1% from its 52-week high, +9.8% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

AXSM$196.14+1.39%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 615.83K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Axsome Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.axsome.com ↗
Price196.14
Change+1.39%
Gap+0.40%
Rel volume0.59×
Avg volume598.81K
Avg $ vol124.36M
SMA 20206.74
SMA 50215.14
SMA 200198.61
Price vs 50-8.83%
Price vs 200-1.24%
MA stackmixed
50/200 cross—
Supertrenddown · 218.84
RSI (14)39
MACD hist-1.04
MACD crossbear · 1d
Stoch %K / %D17 / 11
ADX (14)19
+DI / −DI15 / 31
RSI divergence—
MACD divergence—
ATR %4.20%
ADR %3.65%
52w high255.17
52w low116.01
From 52w high-23.13%
Above 52w low+69.07%
New 52w highNo
SqueezeOff
Bollinger width12.84%
%B0.10
Donchian pos17.48%
Donchian high229.62
Donchian low189.05
AVWAP (52w high)227.24
vs AVWAP high-13.68%
AVWAP (52w low)193.02
vs AVWAP low+1.61%
OBV trendFlat
Chaikin MF (20)-0.08
Today vs 20d0.59×
Avg vol (14d)615.83K
Avg vol (20d)598.81K
Avg $ vol (20d)124.36M
Market cap10.27B
RS Rating86 / 99
RS 3m (vs SPY)-21.85%
RS 6m (vs SPY)+4.42%
RS line new highNo
Trend template5/8
Technical rank49.1
1 week-8.47%
1 month-4.55%
3 months-17.36%
6 months+21.24%
1 year+65.95%
YTD+9.77%
P/E-56.09
P/B123.33
P/S16.09
P/FCF-109.43
EPS-3.68
Div yield—
ROE-219.89%
ROA-24.06%
Debt/Eq2.26
Current1.43
EV/EBITDA—
Gross margin—
Net margin-28.69%
Rev growth65.55%
EPS growth36.22%
Price target290.54
Target upside48.13%
Analyst ratingBuy
Institutional81.38%
Ent. value10.14B
Revenue218.38M
Net income-51.31M
Gross profit—
Free cash flow-93.89M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out51.46M
Employees925
ListedThu, Nov 19, 2015
Free float40.27M
Float %78.7%
Short interest3.08M
Days to cover5.8d
Short volume63.0%
Squeeze score56 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.99 vs −$0.99
Last surprise0.0% beat
Setup gradeD
Conviction31 / 100
Pattern quality—
Tech rank49.1 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance226.51
Support198.62
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AXSM

All disclosures →
No recent disclosed trades by Congress in AXSM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AXSM · open-market 5 sells

InsiderSideShares
TABUTEAU HERRIOT
Chief Executive Officer · Common Stock · 2026-08-06
Exercise4.66K
TABUTEAU HERRIOT
Chief Executive Officer · Common Stock · 2026-08-06
Sell4.66K
TABUTEAU HERRIOT
Chief Executive Officer · Stock Option (Right to Buy) · 2026-08-06
Exercise4.66K
TABUTEAU HERRIOT
Chief Executive Officer · Common Stock · 2026-08-05
Exercise45K
TABUTEAU HERRIOT
Chief Executive Officer · Common Stock · 2026-08-05
Sell45K
TABUTEAU HERRIOT
Chief Executive Officer · Stock Option (Right to Buy) · 2026-08-05
Exercise45K
Mahony Susan
Director · Common Stock · 2026-06-10
Sell300
Coleman Mark
Director · Common Stock · 2026-06-10
Sell643
Mahony Susan
Director · Common Stock · 2026-06-09
Sell300
Saad Mark E
Director · Common Stock · 2026-06-08
Exercise1.43K

SEC filings

EDGAR filings in AXSM · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.